报销
肉芽组织
造粒
再生(生物学)
基质(化学分析)
生物医学工程
伤口愈合
医学
生化工程
材料科学
外科
复合材料
工程类
医疗保健
经济
细胞生物学
生物
经济增长
作者
Allegra L Fierro,Nour Hijazi,Carolyn Foley,Lauren Rodio,John C Lantis,John C. Lantis II
标识
DOI:10.52198/24.sti.44.wh1788
摘要
Cellular and matrix-like products come in many forms. Among them, powdered and micronized formulations have become increasingly available and popular owing to their unique properties and advantages. Powders have increased tissue contact which many believe can enhance granulation tissue formation, they fill irregular and deep cavities, and they can be used in concert with sheet-like products and skin grafts for improved healing. Despite their advantages, powdered products do have certain limitations that hinder their use, including poor insurance coverage and a lack of CPT coding for adequate reimbursement in an outpatient setting, making their use primarily limited to the operating room. Also, most published data on powdered products consists of smaller case studies and case series, with few reports evaluating the efficacy and utility of powdered formulations compared to their sheet-like progenitors. In this manuscript, we organize available powdered matrix products by type of substrate: xenograft, allograft, placental-based, and synthetic, and review the data in support of various products in specific wound types. This review of the supporting literature provides the current body of evidence on the utility of powdered matrices in wounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI